Published in PLoS One on April 27, 2015
Ultrasensitive detection of HIV-1 p24 antigen by a hybrid nanomechanical-optoplasmonic platform with potential for detecting HIV-1 at first week after infection. PLoS One (2017) 0.75
Multi-scale silica structures for improved HIV-1 Capsid (p24) antigen detection. Analyst (2016) 0.75
The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis. J Control Release (2016) 0.75
Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry (1971) 21.72
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS (2003) 11.66
Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science (2003) 8.17
Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med (1991) 7.83
High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med (1991) 7.01
Acute HIV-1 Infection. N Engl J Med (2011) 4.84
Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA). Clin Chem (2005) 4.68
Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs. Lancet (1986) 2.92
Early detection of antibodies to HIV-1 by third-generation assays. Lancet (1992) 2.18
The detection of acute HIV infection. J Infect Dis (2010) 2.14
Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS (2000) 2.08
Enzyme-linked fluorescence assay: Ultrasensitive solid-phase assay for detection of human rotavirus. J Clin Microbiol (1979) 2.08
p24 Antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection. J Clin Microbiol (2003) 1.64
Plasmonic ELISA for the ultrasensitive detection of disease biomarkers with the naked eye. Nat Nanotechnol (2012) 1.61
Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection. J Infect Dis (1999) 1.58
Access to diagnostics in support of HIV/AIDS and tuberculosis treatment in developing countries. AIDS (2007) 1.50
Duration of human immunodeficiency virus infection before detection of antibody. Lancet (1989) 1.35
Comparison of fluorescent and colorigenic substrates for enzyme immunoassays. J Clin Microbiol (1982) 1.27
HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 1.24
Nanoparticle-based immunoassays for sensitive and early detection of HIV-1 capsid (p24) antigen. J Infect Dis (2010) 1.19
Enhanced gold nanoparticle based ELISA for a breast cancer biomarker. Anal Chem (2010) 1.15
Enzyme immunoassay and enzyme-linked immunosorbent assay. J Invest Dermatol (2013) 1.13
Nanoparticles for detection and diagnosis. Adv Drug Deliv Rev (2009) 1.08
Low rates of p24 antigen detection using a fourth-generation point of care HIV test. Sex Transm Infect (2010) 1.08
Detection of HIV antigen and specific antibodies to HIV core and envelope proteins in sera of patients with HIV infection. Blood (1987) 1.07
Bacterial expression of the acquired immunodeficiency syndrome retrovirus p24 gag protein and its use as a diagnostic reagent. Proc Natl Acad Sci U S A (1985) 1.04
Highly sensitive protein detection using enzyme-labeled gold nanoparticle probes. Analyst (2009) 1.03
Quantitative enzyme immunoassay: current status. Clin Chem (1976) 1.01
Double-codified gold nanolabels for enhanced immunoanalysis. Anal Chem (2007) 0.97
Sensitive sandwich ELISA based on a gold nanoparticle layer for cancer detection. Analyst (2012) 0.96
Failures in the detection of HIV p24 antigen with the Determine HIV-1/2 Ag/Ab Combo rapid test. J Infect Dis (2012) 0.96
HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis. PLoS One (2011) 0.94
Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection. Clin Vaccine Immunol (2010) 0.88
Comparison of alkaline phosphatase and horseradish peroxidase conjugated antisera in the ELISA test for antibodies to reovirus 3, mouse hepatitis and Sendai viruses. Lab Anim (1981) 0.85
Enhanced sensitivity and precision in an enzyme-linked immunosorbent assay with fluorogenic substrates compared with commonly used chromogenic substrates. Anal Biochem (2005) 0.85
Two types of nanoparticle-based bio-barcode amplification assays to detect HIV-1 p24 antigen. Virol J (2012) 0.84
Development of a sensitive ELISA for HIV-1 p24 antigen using a fluorogenic substrate for monitoring HIV-1 replication in vitro. J Virol Methods (1992) 0.81
Ultrasensitive enzyme immunoassay. Clin Chim Acta (1990) 0.79
Measurement of human immunodeficiency virus type 1 p24 in serum by an ultrasensitive enzyme immunoassay, the two-site immune complex transfer enzyme immunoassay. J Clin Microbiol (1995) 0.79
Tandem conjugation of enzyme and antibody on silica nanoparticle for enzyme immunoassay. Anal Biochem (2010) 0.79
Ultrasensitive and more specific enzyme immunoassay (immune complex transfer enzyme immunoassay) for p24 antigen of HIV-1 in serum using affinity-purified rabbit anti-p24 Fab' and monoclonal mouse anti-p24 Fab'. J Clin Lab Anal (1996) 0.78
Ultrasensitive densitometry detection of cytokines with nanoparticle-modified aptamers. Clin Chem (2007) 0.78
Evaluation of a newly developed HIV antigen test. J Med Virol (1997) 0.77
Gold nanoparticle layer: a promising platform for ultra-sensitive cancer detection. Langmuir (2011) 0.77
Catalase-coupled gold nanoparticles: comparison between the carbodiimide and biotin-streptavidin methods. Acta Biomater (2011) 0.77
Cost-effectiveness of nucleic acid amplification tests for identifying acute HIV infections. J Clin Microbiol (2011) 0.76
Comparison of enzyme-linked immunosorbent assay with enzyme-linked fluorescence assay with automated readers for detection of rubella virus antibody and herpes simplex virus. J Clin Microbiol (1985) 0.76
Evaluation of the use of chromogenic and fluorogenic substrates in solid-phase enzyme linked immunosorbent assays (ELISA). Biologicals (1990) 0.76